Cytochrome P450 2C19 polymorphism and clopidogrel after MI.
Sanjeev
S
Bhattacharyya
Roby
R
Rakhit
D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics*; D000077144:Clopidogrel; D065731:Cytochrome P-450 CYP2C19; D005500:Follow-Up Studies; D006579:Heterozygote; D006801:Humans; D055118:Medication Adherence; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000235:genetics* / Q000401:mortality; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011110:Polymorphism, Genetic / Q000235:genetics*; D011379:Prognosis; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome
D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D001189:Aryl Hydrocarbon Hydroxylases; C045793:CYP2C19 protein, human; D065731:Cytochrome P-450 CYP2C19; D013988:Ticlopidine